UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.25
-0.70 (-1.59%)
Sep 18, 2026, 4:00 PM EDT - Market closed
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $2.11 billion as of September 18, 2026. Its market cap has increased by 152.46% in one year.
Market Cap
2.11B
Enterprise Value
2.20B
1-Year Change
152.46%
Ranking
Category
Stock Price
$43.25
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $2.11B, an increase of 1,062.22%. That is a compound annual growth rate of 29.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.11B | 92.84% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.26B |
| Ocular Therapeutix | 2.23B |
| Palvella Therapeutics | 2.22B |
| Generate Biomedicines | 2.20B |
| Sarepta Therapeutics | 2.18B |
| Trevi Therapeutics | 2.17B |
| Nuvation Bio | 2.13B |
| Biohaven | 2.10B |